Daily Cosmetic Research Analysis
Analyzed 28 papers and selected 3 impactful papers.
Summary
Analyzed 28 papers and selected 3 impactful articles.
Selected Articles
1. An integrated structural and functional profiling approach uncovers the mechanisms of pregnane X receptor binding and activation by pharmaceutical and environmental compounds.
Using cell-based assays and crystallography, the authors define how two approved drugs, a cosmetic flavor (sclareol), and a halogenated BPA derivative bind to and activate PXR. These ligands differentially induce PXR target genes and promote colon cancer cell proliferation, and the study delivers a reproducible pipeline for PXR ligand identification and risk evaluation.
Impact: Provides mechanistic and structural insights into PXR activation by compounds found in cosmetics and the environment, informing safety-by-design and predicting adverse interactions.
Clinical Implications: Highlights the need to screen cosmetic ingredients and drugs for PXR activation to mitigate drug–drug interactions, endocrine disruption, and possible tumor-promoting effects.
Key Findings
- Two approved drugs, a cosmetic flavor (sclareol), and 2,2'-dichlorobisphenol A differentially bind and activate PXR.
- Ligands induced PXR target genes linked to xenobiotic metabolism and cell proliferation and variably promoted colon cancer cell growth.
- Crystallography revealed distinct binding mechanisms within the PXR ligand-binding domain.
- An integrated structural–functional pipeline was established to identify and characterize PXR ligands for risk assessment.
Methodological Strengths
- Integrated structural biology (X-ray crystallography) with cell-based functional assays.
- Analyzed chemically diverse ligands spanning pharmaceuticals, cosmetic flavoring, and environmental contaminants.
Limitations
- Limited number of ligands examined reduces generalizability.
- Findings are based on in vitro and structural data without in vivo validation.
Future Directions: Expand ligand libraries (including broader cosmetic ingredients), validate PXR activation signatures in vivo, and integrate computational screening to pre-emptively de-risk product development.
The pregnane X receptor (PXR) is a key chemosensory protein that helps the organism adapt to its chemical environment. Indeed, humans are continuously exposed to a wide range of external chemicals, known as xenobiotics, which include environmental pollutants, food components, cosmetics, and pharmaceuticals. PXR has the unique property to sense a large variety of xenobiotics and regulate the expression of detoxifying enzymes and transporters, facilitating the clearance of these chemicals. However, prolonged activation of this pathway can lead to negative effects, such as drug-drug interactions, chemoresistance, endocrine disruption, a heightened risk of metabolic diseases, or enhanced cell growth and tumor aggressiveness. Understanding how PXR interacts with xenobiotics is crucial for predicting, assessing, and preventing the potential impacts of these chemicals on human health. Here, we present the structural and functional analysis of the interaction of PXR with 2 approved drugs (nimodipine and liranaftate), a natural flavor commonly used in cosmetics and the food industry (sclareol), and an environmentally relevant halogenated derivative of the emblematic endocrine disruptor bisphenol A (2,2'-dichlorobisphenol A). Cell-based assays show that these 4 compounds display different PXR binding potencies, stimulate the expression of key target genes related to drug metabolism and cell proliferation, and promote colon cancer cell proliferation to varying degrees. Crystallographic analysis reveals their distinct mechanisms of binding to PXR. The integrated functional and structural characterization pipeline we have established yields critical insights for both environmental risk assessment and the rational development of industrial and pharmaceutical compounds with minimal harmful PXR activity. SIGNIFICANCE STATEMENT: The pregnane X receptor is an off-target of many pharmaceuticals and industrial chemicals whose activation is associated with clinically relevant drug-drug interactions. This study describes a pipeline for the identification and characterization of pregnane X receptor ligands, designed to support environmental risk assessment and the informed design of safer substitutes.
2. Minimally Invasive Remote Approaches Versus Conventional Open Approach in Central Neck Dissection for Patients Undergoing Total Thyroidectomy: A Systematic Review and Meta-Analysis.
Across 11 comparative studies (n=1626), minimally invasive remote approaches to central neck dissection had significantly longer operative times but comparable rates of transient vocal fold paralysis and transient hypoparathyroidism versus open surgery. Lymph node yield was marginally lower with MIRA, supporting COA as the current reference while reserving MIRA for selected patients in high-volume centers prioritizing cosmetic outcomes.
Impact: Synthesizes comparative evidence on cosmesis-driven thyroid cancer surgery, clarifying safety trade-offs and operative efficiency.
Clinical Implications: Open CND should remain the standard; MIRA can be considered for selected patients desiring no-neck-scar approaches at expert centers, with counseling on longer operative times and potential marginally lower node yields.
Key Findings
- MIRA had significantly longer operative times than COA (SMD 1.75; 95% CI 1.39–2.11).
- No significant differences in transient vocal fold paralysis (OR 1.38; 95% CI 0.93–2.04) or transient hypoparathyroidism (OR 0.83; 95% CI 0.46–1.49).
- Intraoperative blood loss, drainage volume, and hospital stay were comparable; lymph node yield was slightly lower with MIRA (small effect size).
Methodological Strengths
- PRISMA 2020–compliant systematic review and meta-analysis.
- Multiple clinically relevant endpoints synthesized across 11 comparative studies.
Limitations
- Heterogeneity and limited reporting prevented quantitative analysis of permanent complications.
- Unclear long-term oncologic outcomes limit definitive equivalence conclusions.
Future Directions: Well-designed prospective comparative studies with standardized oncologic endpoints and patient-reported cosmetic outcomes are needed to define MIRA's role.
BACKGROUND: Total thyroidectomy (TT) with central neck dissection (CND) is the standard surgical approach in selected thyroid cancer patients. Minimally invasive remote approaches (MIRA), either robotic or endoscopic, have been developed to improve cosmetic outcomes, but their oncological safety and efficacy remain debated. OBJECTIVE: To compare MIRA and the conventional open approach (COA) for CND during TT in terms of surgical outcomes, postoperative complications, and oncologic adequacy. METHODS: Following PRISMA 2020 guidelines, a systematic review and meta-analysis was conducted. PubMed/MEDLINE, Cochrane Library, and Scopus databases were searched up to November 24, 2025. Only comparative studies including TT and CND (either ipsilateral or bilateral) in thyroid carcinoma patients were included. Primary outcomes of interest were differences in operative time, rates of transient and permanent vocal fold paralysis, and incidence of transient and permanent hypoparathyroidism. RESULTS: Eleven comparative studies including 1626 patients were analyzed. MIRA was associated with a significantly longer operative time compared with COA (standardized mean difference (SMD) 1.75; 95% CI 1.39-2.11). No significant differences were observed between the two techniques in terms of transient vocal fold paralysis (OR 1.38; 95% CI 0.93-2.04) or transient hypoparathyroidism (OR 0.83; 95% CI 0.46-1.49). Intraoperative blood loss, postoperative drainage volume, and length of hospital stay were comparable between groups. The number of retrieved lymph nodes was slightly lower in the MIRA group, although the effect size was small (SMD -0.12; 95% CI -0.26 to -0.003). Due to limited and inconsistent reporting, permanent vocal fold paralysis and permanent hypoparathyroidism could not be quantitatively analyzed. CONCLUSION: MIRA for CND during TT appears to be feasible and safe in carefully selected thyroid cancer patients, with postoperative complication rates comparable to those of the COA. However, given the longer operative times and the limited evidence on long-term oncologic outcomes, the COA should remain the reference standard, while MIRA may be considered in selected patients at specialized high-volume centers.
3. Effect of cosmetic whitening ingredients' lipophilicity on melanocyte cytotoxicity: A systematic review.
This systematic review extracted assay conditions, mechanisms, cLogP, and viability data from 11 studies and computed IC50 values for cosmetic whitening ingredients, finding a moderate positive correlation between ingredient lipophilicity and melanocyte cytotoxicity. The work underscores regulatory gaps and the need for standardized, premarket toxicity assessment for tyrosinase inhibitors.
Impact: Provides quantitative, mechanism-linked toxicology across whitening actives and highlights systemic regulatory blind spots relevant to consumer safety.
Clinical Implications: Clinicians should counsel patients on potential risks of whitening agents and consider lipophilicity as a predictor of melanocyte toxicity; regulators and manufacturers should adopt standardized in vitro cytotoxicity benchmarks.
Key Findings
- Across 11 studies, IC50 values for whitening actives were computed from MTT assays and correlated with cLogP.
- Ingredient lipophilicity showed a moderate positive correlation with melanocyte cytotoxicity.
- Regulatory frameworks (e.g., ASEAN directive) omit many novel whitening agents, and safety oversight often relies on manufacturers.
Methodological Strengths
- Systematic database search with extraction of mechanistic and physicochemical parameters.
- Quantitative IC50 calculation using standardized drc-R modeling and regression analysis.
Limitations
- Only 11 studies with heterogeneous assays and conditions limit external validity.
- In vitro cytotoxicity may not fully translate to in vivo skin exposure scenarios.
Future Directions: Standardize melanocyte toxicity assays across cell models and exposure conditions, and integrate in vitro-to-in vivo extrapolation to inform regulatory thresholds.
Tyrosinase is an enzyme involved in the early stages of melanin synthesis. Melanin, which gives skin its pigment, is the most targeted molecule in the development of skin-whitening cosmetic products. Consequential risks of chemically induced skin diseases are associated with the usage of skin-whitening products that contain tyrosinase-inhibiting compounds. Currently, products containing tyrosinase inhibitors on the market lack collective analysis of their toxicity on melanocytes. Moreover, national regulatory agencies (e.g., FDA) place the burden of ensuring the safety of whitening products on manufacturers, risking bias and selective reporting. In fact, the ASEAN Cosmetic Directive does not include more than half of the 'novel' whitening agents currently on the market. This review describes the relationship of lipophilicity of cosmetic whitening ingredients (CWI) with melanocyte cytotoxicity. A systematic search of databases using the phrase (((Skin Whitening) OR (Skin Brightening) OR (Skin Lightening) OR (Skin Bleaching)) AND ((Melanocyte Cytotoxicity) OR (Cytotoxicity) OR (Cytotoxic Effect)) AND Mechanism)) was carried out. Data such as the assay and medium used, mechanism of action, cLogP, and cell viability were extracted from the 11 articles in the study. The cell viability data and respective concentration used for the MTT assays were used to calculate the IC50 values of each CWI using the drc-R package in R. The identified CWIs were categorized by their respective lipophilicity; subsequently, linear regression analysis was conducted. It was revealed that the cLogP of the CWIs was able to exhibit a moderate positive correlation between IC50 values (R